文献速递口腔修复与种植口腔颌面外科

迷你猪上颌窦提升模型中rhBMP-2/ACS联合陶瓷骨材料的效果

Sinus augmentation using rhBMP-2/ACS in a mini-pig model: Influence of an adjunctive ceramic bone biomaterial.
PubMed 文献 · J Clin Periodontol · 2018-06-19

8周后结果显示,联合陶瓷材料未显著增强局部骨形成(9.0±1.5至9.7±2.1 mm vs 单独8.6±1.1 mm,p>0.05),不同rhBMP-2剂量(约0.4-1.7 mg/窦)对骨形成/骨整合也无明显影响。结论认为rhBMP-2/ACS可有效支持窦提升中的骨形成,但添加陶瓷骨材料无额外生物学优势。

要点

  • rhBMP-2/ACS在迷你猪上颌窦提升中可支持显著的骨形成与种植体骨整合。
  • 联合双相陶瓷骨材料未显著增强局部骨形成,p>0.05。
  • rhBMP-2剂量约0.4-1.7 mg/窦范围内变化对骨形成/骨整合无明显影响。

核心结论

  • rhBMP-2/ACS在迷你猪上颌窦提升模型中支持显著骨形成/骨整合,是窦提升的有效替代方案;但添加陶瓷骨材料未产生有意义的生物学优势。

研究设计与样本

  • 十二只成年Göttingen迷你猪接受双侧上颌窦提升,随机分配rhBMP-2/ACS单独或联合双相陶瓷(15%/85% HA/β-TCP)按3:1、1:1、1:3比例,对应rhBMP-2/ACS分数100%、75%、50%、25%。
  • 所有位点植入体积4 cc,每侧植入两枚螺纹种植体(ø4.0 × 11.5 mm),8周后行组织学分析。

主要发现

  • rhBMP-2/ACS联合陶瓷骨材料组骨形成范围为9.0 ± 1.5至9.7 ± 2.1 mm,单独rhBMP-2/ACS组为8.6 ± 1.1 mm,组间差异无统计学意义(p > 0.05)。
  • rhBMP-2/ACS与陶瓷基质比例变化使rhBMP-2剂量约为0.4、0.9、1.3、1.7 mg/窦,未明显影响骨形成/骨整合。
  • 所有动物术后至拆线期间观察到眶下局部肿胀,手术实施与愈合总体平稳。

关键数值与推荐

  • rhBMP-2浓度调整为0.43 mg/cc,所有位点植入体积4 cc。
  • 陶瓷骨材料为双相陶瓷,组成15%/85% HA/β-TCP。
  • rhBMP-2/ACS与陶瓷比例3:1、1:1、1:3对应rhBMP-2/ACS分数100%、75%、50%、25%。

临床怎么用

  • 在迷你猪窦提升模型中,rhBMP-2/ACS可支持骨形成与种植体骨整合,或可作为窦提升的替代方案。
  • 联合陶瓷骨材料未显示额外生物学益处,临床选择联合方案时需权衡。

局限性

  • 研究为动物模型(迷你猪),结果外推至人类需谨慎。
  • 观察期仅8周,长期效果未评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge carrier (rhBMP-2/ACS) has been shown to support significant bone formation when used to augment the maxillary sinus for implant dentistry. Nevertheless, bone biomaterials have been suggested to extend rhBMP-2/ACS with limited support of the merits of such approaches. OBJECTIVES: To evaluate local bone formation/dental implant osseointegration following implantation of rhBMP-2/ACS combined with a ceramic bone biomaterial using a mini-pig sinus augmentation model. METHODS: Twelve adult Göttingen mini-pigs received rhBMP-2/ACS (rhBMP-2 adjusted to 0.43 mg/cc) alone or combined with an off-the-shelf biphasic ceramic (15%/85% HA/ß-TCP) biomaterial at 3:1, 1:1 and 1:3 ratios randomized to contra-lateral maxillary sinus sites yielding rhBMP-2/ACS fractions of 100%, 75%, 50% and 25%, respectively. A 4-cc implant volume was used for all sites. Two threaded dental implants (ø4.0 × 11.5 mm) were placed at each site. The animals were euthanized at 8 weeks for histologic analysis. RESULTS: Surgical execution and healing were generally uneventful, infraorbital local swelling was observed in all animals until suture removal. rhBMP-2/ACS combined with the ceramic biomaterial did not significantly enhance local bone formation (range 9.0 ± 1.5 to 9.7 ± 2.1 mm) compared with rhBMP-2/ACS alone (8.6 ± 1.1 mm; p > 0.05). Variations in rhBMP-2/ACS to ceramic matrix ratios yielding rhBMP-2 doses approximating 0.4, 0.9, 1.3 and 1.7 mg/sinus did not appreciably influence bone formation/osseointegration. CONCLUSIONS: Whereas rhBMP-2/ACS supports significant bone formation/osseointegration in the mini-pig sinus augmentation model and thus appears an effective alternative for sinus augmentation procedures, adding a ceramic biomaterial to rhBMP-2/ACS does not produce meaningful biological advantages.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Susin C, Lee J, Fiorini T, et al. Sinus augmentation using rhBMP-2/ACS in a mini-pig model: Influence of an adjunctive ceramic bone biomaterial. J Clin Periodontol. 2018. PMID: 29757470. doi:10.1111/jcpe.12921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。